Skip to main content
Journal ArticleOPEN ACCESS

Immune-mediated drug-induced liver injury secondary to Omeprazole: A case report

Clinical Case Reports (2020) 8(12) 3421-3426
DOI: 10.1002/ccr3.3421
2Citations
Citations of this article
22Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Omeprazole is a rare cause of DILI with autoimmune hepatitis features and should be considered when seeing patients with acute liver injury. The causative drug should be promptly identified and discontinued to avoid any permanent liver damage.

Author supplied keywords

Cite

CITATION STYLE

APA

Seife Hassen, S., Ata, F., Bint I Bilal, A., Salih Ali, M., Petkar, M., Awad Elzouki, A. Y., & Zahid, M. (2020). Immune-mediated drug-induced liver injury secondary to Omeprazole: A case report. Clinical Case Reports, 8(12), 3421–3426. https://doi.org/10.1002/ccr3.3421

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free